Rush to judgment...FDA v. American College of OBGYNs

OTHERWISE: Rush to judgment...FDA v. American College of OBGYNs

The Supreme Court, 6-3, continuing its pattern of early intervention in matters before the District and Courts of Appeals, has stayed an order of the District Court which had enjoined the FDA's requirement that a woman may be dispensed mifepristone, an abortifacient drug, must appear in person at a hospital or doctor's office.